IEEE Spectrum on MSN
The millisecond that could change cancer treatment
FLASH therapy uses a precise burst of ultrahigh-power radiation to kill tumors and spare healthy tissue ...
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. engages in the research and development, manufacturing, marketing and service of medical devices. It products include patient monitoring, ultrasound, ...
Background Silicosis, a chronic respiratory disease caused by crystalline silica exposure, is a persistent global lung health issue. No systematic review of the relationship between cumulative ...
Studies estimating cancer risk from CT radiation use data from different people exposed to different radiation (like atomic bomb survivors). The way these studies estimate CT radiation may not match ...
AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical CDMO, announced that it has supplied the successful dosing of the first ...
First radiotherapeutic agent developed by Radiopharm Ventures, the joint venture between Radiopharm Theranostics and MD Anderson Cancer Center Preclinical animal studies of BetaBart (RV-01) have demon ...
Previous studies have shown that, for patients with four or fewer brain tumors, stereotactic radiation—which uses focused beams of high-dose radiation to target individual tumors—improves cognitive ...
Hosted on MSN
Wednesday's daily dose: A new mRNA flu vaccine, robotic surgery milestone and lung cancer screening
From a potential new flu vaccine to a groundbreaking surgical first and critical health reminders, here's today's essential health news. Young voters are turning away from Trump. Here’s why Study of ...
Radiation therapy is one of the most effective treatments for many kinds of cancer, helping to destroy tumours and save lives. Because these treatments use high‑energy radiation directed at specific ...
Duplicate medical records were associated with a 32% longer hospital length of stay. HealthDay News — Patients with duplicate medical charts have increased odds of adverse patient outcomes, including ...
Eohilia (budesonide) comes in the form of a corticosteroid oral suspension and is prescribed for eosinophilic esophagitis in people ages 11 years and older. Eohilia’s dosage is typically 2 milligrams ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results